Topics

Clinical trials

Moderna spars with US scientists over COVID-19 vaccine trials

Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials

By: Marisa Taylor and Robin Respaut
Source: Reuters
Date of Publication: July 7th, 2020
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc, one of the leading developers, Reuters has learned.
Pfizer reports encouraging early covid-19 vaccine data

Pfizer reports encouraging early coronavirus vaccine data

By: Carolyn Y. Johnson
Source: The Washington Post
Date of Publication: July 1st, 2020
In a small trial, an experimental vaccine triggered immune responses similar to those in recovered patients.
Regeneron Begins Testing Coronavirus Antibody Cocktail Therapy - WSJ

Regeneron Begins Testing Coronavirus Antibody Cocktail Therapy

By: Jonathan D. Rockoff
Source: The Wall Street Journal
Date of Publication: June 11th, 2020
If the drug proves to work safely, it could be available for emergency use as early as the fall, company says.
Coronavirus pandemic threatens to delay potentially life-changing, new medicines

Coronavirus pandemic threatens to delay potentially life-changing, new medicines

By: Berkeley Lovelace Jr.
Source: CNBC
Date of Publication: June 19th, 2020
The coronavirus pandemic postponed the start of clinical trials for potentially life-changing, new medicines. It also could delay the time in which some of those drugs will reach the market as the U.S. Food and Drug Administration faces a potential surge in applications amid a pandemic. The full impact of the postponements for testing new drugs, treatments and vaccines for ailments besides Covid-19 may not be known for months.
Exclusive_ Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist

Exclusive: Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist

By: Carl O'Donnell and Michael Erman
Source: Reuters
Date of Publication: June 10th, 2020
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
J&J to begin human trials of COVID-19 vaccine in second half of July

J&J to begin human trials of COVID-19 vaccine in second half of July

By: Saumya Sibi Joseph
Source: Reuters
Date of Publication: June 10th, 2020
Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned, as drugmakers race to develop a shot for the deadly respiratory disease.
A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

By: Nsikan Akpan
Source: National Geographic
Date of Publication: May 29th, 2020
Moderna Therapeutics has just entered phase two of its clinical trials. Here's how mRNA vaccines work and what the latest developments mean.
Eli Lilly starts human study of a potential coronavirus treatment

Eli Lilly starts human study of a potential coronavirus treatment

By: Reuters
Source: CNBC
Date of Publication: June 1st, 2020
Eli Lilly said on Monday it had started an early-stage trial to test its potential treatment for Covid-19, in the world’s first study of an antibody treatment against the disease.
Oracle Therapeutic Learning System Records Effectiveness of COVID-19 Drugs

Oracle Therapeutic Learning System Records Effectiveness of COVID-19 Drugs

By: Oracle
Source: Oracle
Date of Publication: April 1st, 2020
For the last several weeks, Oracle has been actively engaged in the ongoing fight against COVID-19. Our primary goal has been to develop and deploy a series of cloud applications that will gather the data necessary to enable health professionals to answer one critical question: What drugs are effective in treating or preventing the COVID-19 virus?
Johnson&Johnson_vaccine

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

By: Johnson & Johnson
Source: Johnson & Johnson
Date of Publication: March 30th, 2020
Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020. Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capabilities and Additional Production Capacity Outside the U.S. to Begin Production at Risk to Help Ensure Global Vaccine Supply